Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization

BACKGROUND/AIMS: (18)F-Fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) has been used to assess the biological behavior of hepatocellular carcinoma (HCC). In this study, we investigated the usefulness of (18)F-FDG PET for predicting tumor progression and survival in patients with inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Jin, Kim, Young Seok, Cho, Youn Hee, Jang, Hee Yoon, Song, Jeong-Yeop, Lee, Sae Hwan, Jeong, Soung Won, Kim, Sang Gyune, Jang, Jae Young, Kim, Hong Su, Kim, Boo Sung, Lee, Won Hyung, Park, Jung Mi, Lee, Jae Myung, Lee, Min Hee, Choi, Deuk Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438285/
https://www.ncbi.nlm.nih.gov/pubmed/25995661
http://dx.doi.org/10.3904/kjim.2015.30.3.308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438285/
https://www.ncbi.nlm.nih.gov/pubmed/25995661
http://dx.doi.org/10.3904/kjim.2015.30.3.308

Ejemplares similares